Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone implants for opioid addiction
NCT00521157Phase 3Completed
- Sponsor
- University of Oslo
- Start
- Jan 2006
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of naltrexone in opioid use disorder (OUD) (2 arms), sponsored by University of Oslo. Primary endpoints: Drug use at 6 months, Days in work or education at 12 months and 1 more. Started Jan 2006; status: completed.
02
Drugs
naltrexone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT00521157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00521157.